Norton Rose Fulbright advises on ADQ’s acquisition of Birgi Mefar Group
Global law firm Norton Rose Fulbright advised the shareholders of Turkish pharmaceuticals company Birgi Mefar Group (BMG) on the sale of 100% of its shares to Abu Dhabi investment and holding company ADQ.
BMG is one of Turkey’s leading producers of sterile injectable products, such as vials and pre-filled syringes for vaccines, and has operations in over 30 countries. ADQ is an Abu Dhabi-based investment and holding company with investments in sectors including energy and utilities, food and agriculture, healthcare and life sciences, and mobility and logistics.
Norton Rose Fulbright’s team, led by corporate partners Ayşe Yüksel Mahfoud and Claire O’Donnell - with additional input from partner Matt Foster - worked in collaboration with Pekin Bayar Mizrahi, Norton Rose Fulbright’s alliance firm in Turkey, on the transaction.
